Ardea Biosciences, Inc.
Ardea Biosciences Announces Progress of Clinical Development Programs and Reports Third Quarter and Year-to-Date 2008 Financial Results
Published in Cancer Weekly, December 2nd, 2008
"We have continued to make significant progress since providing our second quarter 2008 update. In August, we initiated a Phase 1 study in normal healthy volunteers of RDEA594, our lead product candidate for the treatment of hyperuricemia and gout, and recently reported positive preliminary results from that trial, including a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-12-02)
More Articles from Cancer Weekly
- Breast Cancer
New Patient Study Suggests Siemens Non-Invasive Blood Test May Have a Role in Monitoring Breast Cancer Patients' Response to Herceptin* (trastuzumab) Therapy - Cancer Vaccines
Data on cancer vaccines detailed by J.B. Hansen and co-authors - Cancer Vaccines
New cancer vaccines research reported from K.E. Lasser and co-authors - Cancer Vaccines
Research from L.M. Kollar and co-researchers yields new findings on cancer vaccines - Cancer Vaccines
Research on cancer vaccines reported by A. Berntsen et al - Cancer Vaccines
Researchers' work from University of Michigan focuses on cancer vaccines - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
